Combining COVID-19 and seasonal influenza vaccines together to increase the acceptance of newly developed vaccines in the Eastern Mediterranean Region: a cross-sectional studyCOVID-19vaccine hesitancyseasonal influenza vaccinehealth promotionEastern Mediterranean Region...
introduced the current achievements: research on the safety and validity of experimental animal for attenuated influenza vector vaccine is ongoing and pre clinical trial research for vaccine candidates and application for clinical trial are expected by the end of April; animal experiments on mice and ...
The COVID-19 vaccine has been a miraculous, life-saving advance, offering staggering efficacy in adults, and was developed with astonishing speed. The time from sequencing the virus to authorizing the first COVID-19 vaccine was so brisk even the optimists appear close-minded. Yet, simultaneously...
Identifying and understanding COVID-19 vaccine hesitancy within distinct populations may aid future public health messaging. Using nationally representative data from the general adult populations of Ireland (N = 1041) and the United Kingdom (UK;N = 2025), we found that vaccine hesitancy/...
The article also provides insight into different COVID-19 vaccine platforms, their preparation, working, efficacy, and side effects. Keywords: SARS-CoV-2 infection; polymeric nanovaccine; humoral immunity; cell-mediated immunity1. Introduction According to the World Health Organization (WHO), unknown ...
Before COVID-19, his team was working onmRNA flu vaccines, as well as candidates for genital herpes and HIV. Influenza viruses acquire variations from season to season, making them excellent candidates for a rapid “vaccine on demand” platform. ...
Previous studies on the role of these drugs on the level of immunogenicity and the experience on the seasonal influenza vaccine have demonstrated that after administeration of the COVID-19 vaccine and stopping the drug, the immunogenicity of the vaccine increased for a maximum of two weeks ...
vaccine-induced T cell responses were unaffected by current SARS-CoV-2 variants of concern. Together, CoVac-1 showed a favourable safety profile and induced broad, potent and variant of concern-independent T cell responses, supporting the presently ongoing evaluation in a phase II trial for patien...
low-cost nudges may be effective in this regard. Two recent large-scale studies in the United States found that vaccination appointment reminder messages from healthcare providers increased influenza vaccine uptake53,54. Similar interventions have proven effective in increasing immunization in LMIC context...
Since the end of the year 2019, the whole world is experiencing a global emergency due to the COVID-19 pandemic. The major sectors including industry, econ